Literature DB >> 20084545

Moderate physical activity and breast cancer risk: the effect of menopausal status.

Angélica Angeles-Llerenas1, Carolina Ortega-Olvera, Edelmiro Pérez-Rodríguez, Jesús Pablo Esparza-Cano, Eduardo Lazcano-Ponce, Isabelle Romieu, Gabriela Torres-Mejía.   

Abstract

INTRODUCTION: It has been suggested that both moderate-and vigorous-intensity physical activity reduces the risk of breast cancer. However, the effect of moderate-intensity physical activity on breast cancer risk has not been consistently evaluated by menopausal status and has not been evaluated in Mexican women.
OBJECTIVE: To evaluate the effect of moderate-intensity physical activity (h/week and MET-h/week) on the risk of breast cancer by menopausal status in Mexican women.
METHODS: A population-based case-control study was conducted in Mexico. One thousand incident cases and 1,074 matched controls to cases by 5 years of age, site and health institution participated in the study. Women provided information on health, diet and physical activity by means of an in-person interview. Anthropometric measurements and blood samples were obtained from all women. A conditional logistic regression model was used to assess this association.
RESULTS: Participating in moderate-intensity physical activity decreased the risk of BC in both pre- and postmenopausal women (OR = 0.96; 95% CI 0.92.-0.99; OR = 0.90; 95% CI 0.86-0.93, respectively) for every 3 h per week of moderate-intensity physical activity. There was a statistically significant modification effect by menopausal status (p = 0.009).
CONCLUSIONS: Strategies need to be identified that will engage women in physical activity programs.

Entities:  

Mesh:

Year:  2010        PMID: 20084545     DOI: 10.1007/s10552-009-9487-8

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  31 in total

1.  A Pooled Analysis of Breastfeeding and Breast Cancer Risk by Hormone Receptor Status in Parous Hispanic Women.

Authors:  Meera Sangaramoorthy; Lisa M Hines; Gabriela Torres-Mejía; Amanda I Phipps; Kathy B Baumgartner; Anna H Wu; Jocelyn Koo; Sue A Ingles; Martha L Slattery; Esther M John
Journal:  Epidemiology       Date:  2019-05       Impact factor: 4.822

2.  Cigarette Smoking and Breast Cancer Risk in Hispanic and Non-Hispanic White Women: The Breast Cancer Health Disparities Study.

Authors:  Avonne E Connor; Kathy B Baumgartner; Richard N Baumgartner; Christina M Pinkston; Stephanie D Boone; Esther M John; Gabriela Torres-Mejía; Lisa M Hines; Anna R Giuliano; Roger K Wolff; Martha L Slattery
Journal:  J Womens Health (Larchmt)       Date:  2015-12-18       Impact factor: 2.681

3.  Genetic variants and non-genetic factors predict circulating vitamin D levels in Hispanic and non-Hispanic White women: the Breast Cancer Health Disparities Study.

Authors:  Wei Wang; Sue Ann Ingles; Gabriela Torres-Mejía; Mariana C Stern; Frank Z Stanczyk; Gary G Schwartz; David O Nelson; Laura Fejerman; Roger K Wolff; Martha L Slattery; Esther M John
Journal:  Int J Mol Epidemiol Genet       Date:  2014-02-17

4.  Association between rs2981582 polymorphism in the FGFR2 gene and the risk of breast cancer in Mexican women.

Authors:  Efrén Murillo-Zamora; Hortensia Moreno-Macías; Elad Ziv; Isabelle Romieu; Eduardo Lazcano-Ponce; Angélica Angeles-Llerenas; Edelmiro Pérez-Rodríguez; Silvia Vidal-Millán; Laura Fejerman; Gabriela Torres-Mejía
Journal:  Arch Med Res       Date:  2013-09-18       Impact factor: 2.235

5.  Genetic variants in interleukin genes are associated with breast cancer risk and survival in a genetically admixed population: the Breast Cancer Health Disparities Study.

Authors:  Martha L Slattery; Jennifer S Herrick; Gabriella Torres-Mejia; Esther M John; Anna R Giuliano; Lisa M Hines; Mariana C Stern; Kathy B Baumgartner; Angela P Presson; Roger K Wolff
Journal:  Carcinogenesis       Date:  2014-03-26       Impact factor: 4.944

6.  Diet and lifestyle factors modify immune/inflammation response genes to alter breast cancer risk and prognosis: the Breast Cancer Health Disparities Study.

Authors:  Martha L Slattery; Abbie Lundgreen; Gabriela Torres-Mejia; Roger K Wolff; Lisa Hines; Kathy Baumgartner; Esther M John
Journal:  Mutat Res       Date:  2014-12       Impact factor: 2.433

7.  Associations between ALOX, COX, and CRP polymorphisms and breast cancer among Hispanic and non-Hispanic white women: The breast cancer health disparities study.

Authors:  Avonne E Connor; Richard N Baumgartner; Kathy B Baumgartner; Christina M Pinkston; Stephanie D Boone; Esther M John; Gabriela Torres-Mejía; Lisa M Hines; Anna R Giuliano; Roger K Wolff; Martha L Slattery
Journal:  Mol Carcinog       Date:  2014-10-22       Impact factor: 4.784

8.  Active and passive cigarette smoking and mortality among Hispanic and non-Hispanic white women diagnosed with invasive breast cancer.

Authors:  Stephanie D Boone; Kathy B Baumgartner; Richard N Baumgartner; Avonne E Connor; Esther M John; Anna R Giuliano; Lisa M Hines; Shesh N Rai; Elizabeth C Riley; Christina M Pinkston; Roger K Wolff; Martha L Slattery
Journal:  Ann Epidemiol       Date:  2015-08-28       Impact factor: 3.797

9.  Associations between CYP19A1 polymorphisms, Native American ancestry, and breast cancer risk and mortality: the Breast Cancer Health Disparities Study.

Authors:  Stephanie D Boone; Kathy B Baumgartner; Richard N Baumgartner; Avonne E Connor; Christina M Pinkston; Shesh N Rai; Elizabeth C Riley; Lisa M Hines; Anna R Giuliano; Esther M John; Mariana C Stern; Gabriela Torres-Mejía; Roger K Wolff; Martha L Slattery
Journal:  Cancer Causes Control       Date:  2014-08-05       Impact factor: 2.506

10.  Interaction between common breast cancer susceptibility variants, genetic ancestry, and nongenetic risk factors in Hispanic women.

Authors:  Laura Fejerman; Mariana C Stern; Esther M John; Gabriela Torres-Mejía; Lisa M Hines; Roger K Wolff; Kathy B Baumgartner; Anna R Giuliano; Elad Ziv; Eliseo J Pérez-Stable; Martha L Slattery
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-09-12       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.